Dept. of Obstetrics and Gynecology (산부인과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

MicroRNA expression profiles in serous ovarian carcinoma

Eun Ji Nam ; Heejei Yoon ; Sang Wun Kim ; Hoguen Kim ; Young Tae Kim ; Jae Ho... CLINICAL CANCER RESEARCH, Vol.14(9) : 2690-2695, 2008

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial o...

HanByoul Cho ; Hye Won Hur ; Sang Wun Kim ; Sung Hoon Kim ; Jae Hoon Kim ; Yo... CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.58(1) : 15-23, 2009

Osteopontin as apotential diagnostic biomarker for ovarian cancer

Jae Hoon Kim ; Steven J. Skates ; Toshimitsu Uede ; Kwong Kwok Wong ; John O.... JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, Vol.287(13) : 1671-1679, 2002
This table browses all dspace content
Issue DateTitleJournal Title
2022An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVALINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022RANDOMIZED COMPARISON BETWEEN SENTINEL LYMPH NODE MAPPING USING INDOCYANINE GREEN PLUS A FLUORESCENT CAMERA VERSUS LYMPH NODE DISSECTION IN CLINICAL STAGE I-II ENDOMETRIAL CANCER (KGOG2029/SELYE)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative imagesINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PROSPECTIVE MULTI-INSTITUTIONAL PHASE III TRIAL OF STANDARD OF CARE THERAPY WITH OR WITHOUT STEROTACTIC ABLATIVE RADIATION THERAPY FOR RECURRENT OVARIAN CANCER (SABR-ROC, KGOG 3064/KROG 2204)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022LAPAROSCOPIC LEFT COMMON ILIAC VEIN INJURY AND REPAIRINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022PREDICTION OF SURGICAL OUTCOMES OF INTERVAL DEBULKING SURGERY (IDS) USING IN ADVANCED OVARIAN CANCER: A NOVEL SCORING SYSTEM USING POST-NEOADJUVANT CHEMOTHERAPY (NAC) COMPUTED TOMOGRAPHY (CT)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMAINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY?INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Preterm labor with intact membranes: a simple noninvasive method to identify patients at risk for intra-amniotic infection and/or inflammationJOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
2022Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes CLINICAL CANCER RESEARCH
2022Factors influencing perceived communication quality for successful fertility preservation counseling for adolescent and young adult cancer patients and their caregivers in KoreaSUPPORTIVE CARE IN CANCER
2022TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis CANCER GENOMICS & PROTEOMICS
2022Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE) JOURNAL OF GYNECOLOGIC ONCOLOGY

Browse

Links